Selank + Semax 20mg

☆☆☆☆☆

This listing is for 1 × Selank + Semax 20mg vial only. This research peptide blend combines Selank, an anxiolytic peptide (10mg), with Semax, a nootropic peptide (10mg), for a total of 20mg in a single lyophilised formulation. Supplied for cognitive function research, anxiety modulation pathway studies, and neuroprotection investigations in experimental models. Specifications include ≥99% purity, lyophilised white powder form, and storage at -20°C (long-term).

Research Use Only: This product is strictly for laboratory research and is not intended for human or veterinary consumption, therapeutic use, diagnostic use, or clinical application.

Useful Resources: Concentration Calculator | What Is Selank? | What Is Semax? | Selank vs Semax | COA & Lab Testing

Current Batch

S826X7A2-SEL20Now Shipping

This batch has third party test results

4 Tests Available

Test Summary

Purity

99.81%

HPLC

Pass

Identity

Confirmed

LC-MS

Pass

Net Peptide Content

21.35 mg (Semax 10.78 mg + Selank 10.57 mg)

Pass

Fentanyl Screen

Not Detected

Safety screen

Pass

Verified by ILS Laboratories|ISO/IEC 17025 Accredited

Official COA Verification

Independent Lab Verification

Scan the QR code to verify this certificate directly on the ILS Laboratories secure portal.

Access Code

D5UU4LNW

$149.95 AUD

Quantity

Product Overview

Understanding Selank + Semax 20mg

Selank + Semax 20mg is a dual nootropic peptide blend combining Selank, an anxiolytic heptapeptide (10mg), with Semax, an ACTH-derived nootropic peptide (10mg), in a single lyophilised formulation for in-vitro laboratory research. This combination enables investigation of anxiolytic and cognitive enhancement pathway interactions, BDNF expression modulation, and neuroprotective signalling mechanisms in laboratory models. Products selected for website presentation meet Solatide Biosciences' ≥99% purity standard based on available third-party documentation.

Research Applications

•Cognitive Function Research: Investigate Semax-mediated ACTH receptor pathway activation and cognitive signalling pathway modulation in experimental cell models.
•Anxiety Modulation Studies: Study Selank anxiolytic peptide pathway interactions, GABAergic modulation, and anxiety pathway regulation in vitro.
•Neuroprotection Investigation: Examine combined Selank and Semax neuroprotective signalling, BDNF expression modulation, and neuronal pathway analysis in laboratory models.
•Comparative Single vs Combination Peptide Studies: Compare combination blend activity against individual Selank or Semax controls in receptor pharmacology assays.
This analytical standard is strictly for in-vitro laboratory research use only.

Technical Specifications

Technical Parameter

Laboratory Specification

Purity

≥99% based on available third-party documentation

Composition

Selank 10mg + Semax 10mg

Total Content

20mg per vial

Appearance

White Lyophilised Powder

Storage

-20°C (long-term)

Batch-specific third-party documentation available. Reports may include testing from independent laboratories such as Janoshik, Chromate, and Freedom Diagnostics, depending on the batch. View our COA & Lab Testing page for details.